NEOPLASMS, OVARIAN
Clinical trials for NEOPLASMS, OVARIAN explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, OVARIAN trials appear
Sign up with your email to follow new studies for NEOPLASMS, OVARIAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat ovarian cancer: targeted drug shows promise
Disease control CompletedThis study tested a new drug, farletuzumab ecteribulin, in 106 women with ovarian cancer that stopped responding to platinum chemotherapy. The drug targets a protein called folate receptor alpha found on cancer cells. Researchers compared it to standard chemotherapy to see if it …
Matched conditions: NEOPLASMS, OVARIAN
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug shows promise against multiple advanced cancers
Disease control CompletedThis study tested a new drug called ESG401 in 156 people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study included many cancer types, such as breast, lung, and colore…
Matched conditions: NEOPLASMS, OVARIAN
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC